These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 38297320)
1. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates. Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma. Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389 [TBL] [Abstract][Full Text] [Related]
3. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma. Cheng L; Mi J; Zhang J; Huang H; Mo Z Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660 [TBL] [Abstract][Full Text] [Related]
4. Low Xie Z; Chen N Transl Cancer Res; 2023 Nov; 12(11):3045-3060. PubMed ID: 38130311 [TBL] [Abstract][Full Text] [Related]
5. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of RAB17 have a poor prognosis in kidney renal clear cell carcinoma and its expression correlates with DNA methylation and immune infiltration. Zeng Z; Zhang Z; Cheng X; Yang H; Gong B; Zhou X; Zhang C; Wang X; Wang G Cell Signal; 2023 Sep; 109():110743. PubMed ID: 37269962 [TBL] [Abstract][Full Text] [Related]
7. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma. Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma. Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674 [No Abstract] [Full Text] [Related]
9. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma. Chen CC; Chu PY; Lin HY Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154 [TBL] [Abstract][Full Text] [Related]
10. Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma. Sun X; Liu P Front Oncol; 2023; 13():1073941. PubMed ID: 36816967 [TBL] [Abstract][Full Text] [Related]
11. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization. Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y Front Immunol; 2023; 14():1224904. PubMed ID: 37809090 [TBL] [Abstract][Full Text] [Related]
12. Correlation of Reduced PTGER3 Expression with Prognosis and Immune Infiltration in Clear Cell Renal Carcinoma. Yang K; Hu B; Zhu G; Yuan D; Wang W; Su H; Liu H; Zhu J Arch Esp Urol; 2023 Jun; 76(4):270-282. PubMed ID: 37455526 [TBL] [Abstract][Full Text] [Related]
13. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment. Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689 [TBL] [Abstract][Full Text] [Related]
14. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma. Jiang H; Chen H; Wan P; Chen N Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866 [TBL] [Abstract][Full Text] [Related]
15. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma. Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412 [No Abstract] [Full Text] [Related]
16. Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma. Zhang J; Zhao Q; Huang H; Lin X BMC Urol; 2024 Jan; 24(1):26. PubMed ID: 38297313 [TBL] [Abstract][Full Text] [Related]
17. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma. Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551 [TBL] [Abstract][Full Text] [Related]
18. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients. Yu J; Mao W; Xu B; Chen M Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306 [TBL] [Abstract][Full Text] [Related]
19. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma. Chen Y; He J; Jin T; Zhang Y; Ou Y J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762 [TBL] [Abstract][Full Text] [Related]
20. Klümper N; Ralser DJ; Bawden EG; Landsberg J; Zarbl R; Kristiansen G; Toma M; Ritter M; Hölzel M; Ellinger J; Dietrich D J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32234847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]